Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GLOBE MEDICAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   6.9% 10.4% 15.5% 16.9% 15.8% 14.5% 16.0% 16.0%   Credit score (0-100)   36 25 12 9 11 14 12 12   Credit rating   BBB BB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   516 -7.8 -128 -15.0 -14.8 -3.2 0.0 0.0   EBITDA   -127 -7.8 -0.6 35.2 -14.8 -3.2 0.0 0.0   EBIT   -130 -7.8 -0.6 35.2 -14.8 -3.2 0.0 0.0   Pre-tax profit (PTP)   -128.8 -22.3 -19.7 9.4 -49.8 -3.5 0.0 0.0   Net earnings   -110.9 -19.5 -19.7 7.4 -49.9 -2.7 0.0 0.0   Pre-tax profit without non-rec. items   -129 -22.3 -19.7 9.4 -14.8 -3.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   583 364 106 113 63.6 60.9 -64.1 -64.1   Interest-bearing liabilities   436 134 599 1,827 85.4 0.0 64.1 64.1   Balance sheet total (assets)   1,354 1,394 859 2,035 159 62.9 0.0 0.0   Net Debt   -530 -204 516 -203 -69.7 -35.3 64.1 64.1     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   516 -7.8 -128 -15.0 -14.8 -3.2 0.0 0.0   Gross profit growth   -42.3% 0.0% -1,543.0% 88.2% 1.5% 78.4% 0.0% 0.0%   Employees   1 1 1 1 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,354 1,394 859 2,035 159 63 0 0   Balance sheet change%   -20.1% 3.0% -38.4% 137.0% -92.2% -60.4% -100.0% 0.0%   Added value   -126.5 -7.8 -0.6 35.2 -14.8 -3.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -6 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -25.1% 100.0% 0.4% -234.8% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -7.3% -0.2% 0.4% 2.6% -1.3% -2.9% 0.0% 0.0%   ROI %   -9.9% -0.4% 0.8% 2.9% -1.4% -3.0% 0.0% 0.0%   ROE %   -15.0% -4.1% -8.4% 6.7% -56.3% -4.4% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   43.1% 26.1% 12.4% 5.6% 40.0% 96.8% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   419.2% 2,633.7% -91,362.1% -576.0% 471.4% 1,107.7% 0.0% 0.0%   Gearing %   74.8% 36.8% 564.2% 1,609.9% 134.2% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.4% 6.8% 6.6% 2.4% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.8 1.4 1.1 1.1 1.7 31.4 0.0 0.0   Current Ratio   1.8 1.4 1.1 1.1 1.7 31.4 0.0 0.0   Cash and cash equivalent   966.7 338.5 82.5 2,029.9 155.0 35.3 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   583.3 363.8 106.1 113.5 63.6 60.9 -32.1 -32.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -127 -8 -1 35 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -127 -8 -1 35 0 0 0 0   EBIT / employee   -130 -8 -1 35 0 0 0 0   Net earnings / employee   -111 -19 -20 7 0 0 0 0